We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.62B
AUM Growth
-$62.4M
Cap. Flow
-$203M
Cap. Flow %
-12.53%
Top 10 Hldgs %
11.78%
Holding
792
New
346
Increased
157
Reduced
185
Closed
89

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
ABBV icon
AbbVie
ABBV
+$29.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.4M
4
EBAY icon
eBay
EBAY
+$20.5M
5
TEAM icon
Atlassian
TEAM
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 18.44%
3 Consumer Discretionary 15.45%
4 Industrials 9.36%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGVC icon
676
Vitamin Cottage Natural Grocers
NGVC
$691M
$141K 0.01%
+14,300
New +$131K
VYGR icon
677
Voyager Therapeutics
VYGR
$187M
$141K 0.01%
+10,078
New +$146K
OSBC icon
678
Old Second Bancorp
OSBC
$1.24B
$139K 0.01%
+10,352
New +$129K
REZI icon
679
Resideo Technologies
REZI
$5.23B
$136K 0.01%
+11,435
New +$130K
SFE
680
DELISTED
Safeguard Scientifics, Inc.
SFE
$133K 0.01%
+12,100
New +$138K
KGC icon
681
Kinross Gold
KGC
$28.5B
$123K 0.01%
+25,900
New +$117K
SPNT icon
682
SiriusPoint
SPNT
$2.98B
$118K 0.01%
11,193
-77,607
-87% -$754K
TGH
683
DELISTED
Textainer Group Holdings limited
TGH
$118K 0.01%
+11,058
New +$108K
JNCE
684
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$116K 0.01%
13,268
-13,632
-51% -$73.7K
CNR
685
DELISTED
Cornerstone Building Brands, Inc.
CNR
$113K 0.01%
+13,307
New +$93.6K
CGEN icon
686
Compugen
CGEN
$216M
$111K 0.01%
+18,700
New +$96.2K
RVSB icon
687
Riverview Bancorp
RVSB
$107M
$111K 0.01%
13,482
+182
+1% +$1.36K
INWK
688
DELISTED
InnerWorkings, Inc.
INWK
$110K 0.01%
+19,900
New +$96.4K
ECOM
689
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$108K 0.01%
12,000
SBT
690
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$107K 0.01%
+13,200
New +$123K
DAKT icon
691
Daktronics
DAKT
$941M
$100K 0.01%
16,358
-1,335
-8% -$8.92K
DHX icon
692
DHI Group
DHX
$166M
$100K 0.01%
33,100
+1,504
+5% +$5.11K
IDT icon
693
IDT Corp
IDT
$1.6B
$93K 0.01%
12,890
+2,000
+18% +$14.4K
AGEN
694
Agenus
AGEN
$249M
$86K 0.01%
+1,077
New +$72.3K
ARAY icon
695
Accuray
ARAY
$28.4M
$84K 0.01%
29,800
-8,300
-22% -$23K
MFIN icon
696
Medallion Financial
MFIN
$226M
$81K 0.01%
11,196
-6,004
-35% -$39.3K
GYRE icon
697
Gyre Therapeutics
GYRE
$662M
$80K ﹤0.01%
1,560
-2,160
-58% -$90.5K
FSM icon
698
Fortuna Silver Mines
FSM
$2.59B
$79K ﹤0.01%
+19,400
New +$63.4K
KDMN
699
DELISTED
Kadmon Holdings, Inc.
KDMN
$77K ﹤0.01%
+16,897
New +$61.8K
BBW icon
700
Build-A-Bear
BBW
$423M
$68K ﹤0.01%
21,100
-8,600
-29% -$27.6K

Similar funds

PDT Partners's Q4 2019 Portfolio in Review

As of Q4 2019, PDT Partners held 792 positions worth $1.62B, down 3.7% from $1.68B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

PDT Partners withdrew a net $203M in Q4 2019, closing 89 positions and reducing 185 holdings. Its most notable exit was Linde, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Micron Technology worth $10.6M.

  • PDT Partners's largest Q4 2019 buy was Micron Technology: 197,601 shares worth $10.6M.
  • PDT Partners added most to Bausch Health in Q4 2019, an estimated $5.3M increase.
  • PDT Partners's biggest Q4 2019 reduction was AbbVie, cutting an estimated $29.9M.
  • PDT Partners fully exited Linde in Q4 2019, selling an estimated $46.2M.
  • PDT Partners's ten largest holdings make up 12% of its $1.62B portfolio in Q4 2019.
  • PDT Partners opened 346 new positions and closed 89 in Q4 2019.
  • PDT Partners's portfolio value fell 3.7% quarter-over-quarter to $1.62B.

Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.